1. Home
  2. MFA vs EVO Comparison

MFA vs EVO Comparison

Compare MFA & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MFA
  • EVO
  • Stock Information
  • Founded
  • MFA 1997
  • EVO 1993
  • Country
  • MFA United States
  • EVO Germany
  • Employees
  • MFA N/A
  • EVO N/A
  • Industry
  • MFA Real Estate Investment Trusts
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • MFA Real Estate
  • EVO Health Care
  • Exchange
  • MFA Nasdaq
  • EVO Nasdaq
  • Market Cap
  • MFA 1.0B
  • EVO 1.2B
  • IPO Year
  • MFA N/A
  • EVO 2021
  • Fundamental
  • Price
  • MFA $9.18
  • EVO $3.93
  • Analyst Decision
  • MFA Buy
  • EVO Strong Buy
  • Analyst Count
  • MFA 7
  • EVO 1
  • Target Price
  • MFA $11.00
  • EVO $7.00
  • AVG Volume (30 Days)
  • MFA 2.0M
  • EVO 43.8K
  • Earning Date
  • MFA 11-06-2025
  • EVO 11-05-2025
  • Dividend Yield
  • MFA 15.72%
  • EVO N/A
  • EPS Growth
  • MFA 41.64
  • EVO N/A
  • EPS
  • MFA 0.88
  • EVO N/A
  • Revenue
  • MFA $284,489,000.00
  • EVO $912,894,891.00
  • Revenue This Year
  • MFA N/A
  • EVO N/A
  • Revenue Next Year
  • MFA $14.85
  • EVO $10.78
  • P/E Ratio
  • MFA $10.41
  • EVO N/A
  • Revenue Growth
  • MFA 9.37
  • EVO N/A
  • 52 Week Low
  • MFA $7.85
  • EVO $2.84
  • 52 Week High
  • MFA $12.78
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • MFA 38.97
  • EVO 60.43
  • Support Level
  • MFA $8.90
  • EVO $3.93
  • Resistance Level
  • MFA $9.36
  • EVO $4.02
  • Average True Range (ATR)
  • MFA 0.18
  • EVO 0.08
  • MACD
  • MFA -0.06
  • EVO 0.04
  • Stochastic Oscillator
  • MFA 24.88
  • EVO 79.94

About MFA MFA Financial Inc.

MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company's reportable segments include mortgage-related assets and Lima One.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: